Medical Systems Biology

The Berlin Institute for Medical Systems Biology (BIMSB)

Systems Biology integrates high-throughput technologies, mathematics, bioinformatics, molecular biology, biochemistry and engineering to derive predictive, quantitative models for biological systems, which may be molecules, cells, organisms or entire species. In combination with biomedical research, Systems Biology has the potential to steer medicine into the next century of personalized medicine.

The Berlin Institute for Medical Systems Biology (BIMSB) was initiated and developed by Nikolaus Rajewsky (BIMSB Scientific Director). BIMSB is an expansion of the MDC into Medical Systems Biology. BIMSB received, starting 2008, 19 Mio € kick-off funding through the competitive federal initiative “Spitzenforschung in den neuen Bundesländern” (BMBF & Senate Berlin). After a highly successful external peer-review, the BMBF decided to provide additional institutionalized funding for BIMSB (17.5 Mio € /year + 2.5 Mio € /year MDC “Eigenanteil”). The Humboldt University included BIMSB in their successful participation in the “Exzellenzinitiative” and provided the real estate on the new life science Campus in Berlin Mitte. This neighborhood is important for the BIMSB scientific mission and promotes collaborations between the HU and the MDC. The BMBF provides additional money for the new building (33.5 Mio €).

So far, BIMSB researchers newly acquired additional 28.7 Mio € in competitive third-party funds by the BMBF, DFG, EC, HFSP, NIH, industry, BIH and DZHK.
Total external funding to date: 47.7 Mio € (competitively acquired) + 86 Mio € (institutionalized funding by the BMBF).

Research and Technologies

Fellowships and Awards

Location and New Building in the Center of Berlin

Collaborations and International Networks

MDC-NYU PhD Exchange Program